The Prostate Cancer Treatment Book
Description:
The latest and most progressive treatment advice from prostate cancer experts at the nation's top medical centers
For each of the nearly 200,000 Americans diagnosed with prostate cancer annually, the months following the diagnosis are a time of momentous decisions and enormous emotional strain. This book offers readers complete answers to all their questions about the best treatment options for fighting and beating prostate cancer. Bringing together the insights and expertise of 21 of the nation's top prostate cancer specialists from the Mayo Clinic, Harvard Medical School, Memorial Sloan-Kettering, the Seattle Prostate Institute, and other leading treatment centers, The Prostate Cancer Treatment Book provides:
- Expert information on all treatment options, including surgery, hormonal treatment, external beam radiation, and more
- In-depth coverage of radioactive seed implantation therapy, the most promising new treatment currently available
- Real-life accounts of dozens of men who beat prostate cancer
Best prices to buy, sell, or rent ISBN 9780071422567
Frequently Asked Questions about The Prostate Cancer Treatment Book
The price for the book starts from $4.99 on Amazon and is available from 25 sellers at the moment.
At BookScouter, the prices for the book start at $1.99. Feel free to explore the offers for the book in used or new condition from various booksellers, aggregated on our website.
If you’re interested in selling back the The Prostate Cancer Treatment Book book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The Prostate Cancer Treatment Book book, the best buyback offer comes from and is $ for the book in good condition.
The The Prostate Cancer Treatment Book book is in very low demand now as the rank for the book is 1,638,325 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.